Glac Biotech is a subsidiary of Center Laboratories, Inc., the largest liquid pharmaceutical manufacturer in Taiwan. As a global expert in probiotic and postbiotic solutions, we have long been dedicated to the field of functional microorganisms, providing a "Farm to Market" vertically integrated service. We operate multiple international-standard manufacturing facilities in Taiwan, possessing robust R&D capabilities and production capacity to ensure a stable supply of high-quality probiotic and postbiotic ingredients.
Core Strengths
| Sales markets | Asia; Australia; Central/South America; Eastern Europe; North America; Western Europe |
|---|---|
| Primary business activity | Manufacturer: Ingredients / Additives |
| Affiliated categories: | Other Microorganisms & Probiotics |Other Prebiotics |Biotic products More |

17 Oct 2023
New Proud Achievement in the World of Postbiotics! Totipro®Postbiotics PE0401 has earned recognition as the FIRST in the world to excel in the "Ingredient: Microbiome Modulation" category, specifically for gastrointestinal function enhancement!
Read more26 Apr 2023
Postbiotics, which consist of inanimate microorganisms and their metabolites, have become a validated class of ingredients supported by a large amount of science evidence showing similar outcomes to probiotics without the challenges of thermo-limitation. Glac Biotech, a contract manufacturer at the forefront of postbiotics in Taiwan, has been able to launch clinically proven ingredients:Totipro® PE0301(Oral Health) and Totipro® PE0401(Inte...
Read more24 Apr 2023
Glac are thrilled to announce that our human breast milk-derived probiotic Bifidobacterium animalis subsp. Lactis CP-9 has been selected as a finalist in the NutraIngredient Awards Europe 2023: Weight Management category!
Read more